Cargando…

Environmental Risk Factors for Talaromycosis Hospitalizations of HIV-Infected Patients in Guangzhou, China: Case Crossover Study

Talaromycosis is a fatal opportunistic infection prevalent in human immunodeficiency virus (HIV)-infected patients, previous studies suggest environmental humidity is associated with monthly talaromycosis hospitalizations of HIV-infected patients, but the acute risk factor remains uncertain. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yaping, Deng, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645774/ https://www.ncbi.nlm.nih.gov/pubmed/34881254 http://dx.doi.org/10.3389/fmed.2021.731188

Ejemplares similares

Disseminated talaromycosis in an HIV-infected patient
por: Chang, Chee Yik, et al.
Publicado: (2021)

Case Report: Metagenomic Next-Generation Sequencing in Diagnosis of Talaromycosis of an Immunocompetent Patient
por: Shi, Jiejun, et al.
Publicado: (2021)

Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)

Non-HIV talaromycosis: Radiological and clinical analysis
por: Li, Xinchun, et al.
Publicado: (2020)

Colesional cutaneous talaromycosis (penicilliosis) and Kaposi sarcoma in an HIV‐infected patient
por: Lai, Shau‐Kong, et al.
Publicado: (2021)

Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China
por: Liu, Hui, et al.
Publicado: (2023)

Drug-related talaromycosis: A case report
por: Lu, Yongsheng, et al.
Publicado: (2020)

Clinical performance of metagenomic next-generation sequencing for the rapid diagnosis of talaromycosis in HIV-infected patients
por: Mao, Yuhuan, et al.
Publicado: (2022)

Talaromycosis (Penicilliosis): A Rare, Opportunistic Systemic Fungal Infection
por: Gorai, Surajit, et al.
Publicado: (2019)

Clinical features of HIV positive talaromycosis marneffei patients and development of a risk prediction model
por: Cen, Jiemei, et al.
Publicado: (2023)

Probable Causes and Risk Factors for Positive SARS-CoV-2 Testing in Recovered Patients: Evidence From Guangzhou, China
por: Luo, Lei, et al.
Publicado: (2021)

Adenovirus infection in children hospitalized with pneumonia in Guangzhou, China
por: Zou, Lirong, et al.
Publicado: (2020)

The Seroprevalence of Dengue Virus Infection and Its Association With Iron (Fe) Level in Pregnant Women in Guangzhou, China
por: Wang, Jiong, et al.
Publicado: (2021)

S2.2c Talaromycosis in HIV-negative patients: challenges and counter-measures
por: Cao, Cunwei
Publicado: (2022)

Advances in diagnosis and treatment of talaromycosis in patients with AIDS
por: Guo, Pengle, et al.
Publicado: (2022)

Multicentre derivation and validation of a prognostic scoring system for mortality assessment in HIV‐infected patients with talaromycosis
por: Qin, Yuanyuan, et al.
Publicado: (2020)

The impact of ambient air pollution on suicide mortality: a case-crossover study in Guangzhou, China
por: Lin, Guo-Zhen, et al.
Publicado: (2016)

Individual exposure to ambient PM(2.5) and hospital admissions for COPD in 110 hospitals: a case-crossover study in Guangzhou, China
por: Jin, Jie-Qi, et al.
Publicado: (2021)

Impact of Meteorological Factors and Southern Oscillation Index on Scrub Typhus Incidence in Guangzhou, Southern China, 2006–2018
por: Lu, Jianyun, et al.
Publicado: (2021)

Prevalence of Noncommunicable Diseases and Their Risk Factors in Guangzhou, China
por: Pan, Bingying, et al.
Publicado: (2014)

Associations between Different Ozone Indicators and Cardiovascular Hospital Admission: A Time-Stratified Case-Crossover Analysis in Guangzhou, China
por: Zhang, Xiangxue, et al.
Publicado: (2023)

Imported Talaromycosis in Oman in Advanced HIV: A Diagnostic Challenge Outside the Endemic Areas
por: Mohsin, Jalila, et al.
Publicado: (2017)

Is stopping secondary prophylaxis safe in HIV‐positive talaromycosis patients? Experience from Myanmar
por: Tun, N, et al.
Publicado: (2020)

Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort
por: Klus, Jonathan, et al.
Publicado: (2021)

Talaromycosis in a Lung Cancer Patient: A Rare Case
por: Ching-López, Rosario, et al.
Publicado: (2020)

Corrigendum: Impact of Meteorological Factors and Southern Oscillation Index on Scrub Typhus Incidence in Guangzhou, Southern China, 2006–2018
por: Lu, Jianyun, et al.
Publicado: (2021)

Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis
por: Narayanasamy, Shanti, et al.
Publicado: (2021)

An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease
por: Zaongo, Silvere D., et al.
Publicado: (2023)

Prevalence, Characterization, and Drug Resistance of Staphylococcus Aureus in Feces From Pediatric Patients in Guangzhou, China
por: Ai, Xiaolan, et al.
Publicado: (2020)

Metagenomic next-generation sequencing for the early diagnosis of talaromycosis in HIV-uninfected patients: five cases report
por: Chen, Qiuhua, et al.
Publicado: (2021)

Rare incidence of non-secretory myeloma with talaromycosis: a case report
por: Qin, Haiting, et al.
Publicado: (2021)

Clinical manifestations and risk factors of adenovirus respiratory infection in hospitalized children in Guangzhou, China during the 2011–2014 period
por: Wu, Pei-Qiong, et al.
Publicado: (2020)

Syphilis Testing as a Proxy Marker for a Subgroup of Men Who Have Sex With Men With a Central Role in HIV-1 Transmission in Guangzhou, China
por: Huang, Liping, et al.
Publicado: (2021)

Successful treatment of AIDS-associated talaromycosis with low-dose itraconazole
por: Pudjiati, Satiti Retno, et al.
Publicado: (2020)

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022)

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China
por: Zhou, Yihong, et al.
Publicado: (2022)

Clinical features of patients with talaromycosis marneffei and microbiological characteristics of the causative strains
por: Peng, Lei, et al.
Publicado: (2022)

622. Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
por: Xu, Helen, et al.
Publicado: (2023)

Incidence of Eczema in Early Infancy and the Prenatal Risk Factors — Guangzhou, Guangdong, China, 2018–2019
por: Deng, Liting, et al.
Publicado: (2021)

P403 Metagenomic sequencing as an effective diagnostic tool for Talaromycosis in HIV-negative patients: A retrospective study
por: Liang, Tianwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mavddemhic0ou80cral41ou0ug